how many americans are on glp 1 drugs GLP-1 Survey: 75% of Users Report Reduced Spending Food, Alcohol 1 in 8 Americans is

Adequate fluid intake becomes even more important when cardiovascular effects are a concern

Retatrutide is a once-a-week injectable peptide that flips on three gut-hormone receptors at the same time: GLP-1, GIP, and glucagon

When combined with diet and exercise, it improves blood sugar control in adults and children ages 10 years and older with Type 2 diabetes

Vecino E, Rodriguez FD, Ruzafa N, Pereiro X, Sharma SC

Percentages are rounded up to one decimal place BID two times a day, BMI body mass index, BMOD intensive behavior modification, GLP-1RA glucagon-like peptide 1 receptor agonist, IBT intensive behavioral therapy, NR not reported, OAD oral antihyperglycemic drug, PT phentermine-topiramate, QD once-daily, TID three times per day a Based on patients achieving 5% weight loss during the run-in period b NB16: sustained-release naltrexone 16 mg per day plus sustained-release bupropion 360 mg per day combined in fixed-dose tablets

The starting price is $149/month compared to $1,000+ for injectable Wegovy